Willow Biosciences Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was CAD 1.17 million compared to CAD 0.821 million a year ago. Net loss was CAD 13.03 million compared to CAD 14.81 million a year ago.

Basic loss per share from continuing operations was CAD 0.1 compared to CAD 0.12 a year ago.